Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: a systematic review
Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: a systematic review
Purpose: Adverse effects of selective serotonin reuptake inhibitors (SSRIs) on sexual function have been an important area of research for many years. However, the duration of SSRI-associated sexual adverse effects, and their possible persistence after treatment discontinuation, is still uncertain. The aims of the current systematic review were first to identify existing evidence of sexual dysfunction following SSRI discontinuation, and to provide an account of reported symptoms and proposed treatment options; and second, to establish whether current literature allows accurate estimates of the prevalence of such sexual dysfunction. Methods: A systematic review was conducted on PubMed, Embase, and Google Scholar; papers with clinical data regarding patients with persistent sexual dysfunction after SSRI treatment suspension were included. Results: Overall, two retrospective interventional studies, six observational studies and 11 case reports were judged eligible for inclusion. It was not possible to determine reliable estimates of prevalence. Similarly, a cause-effect relationship between SSRI exposure and persistent sexual impairment could not be ascertained. Nonetheless, the potential for continued sexual disturbances despite discontinuation could not be entirely ruled out. Conclusions: There is a need to investigate a possible dose–response relationship between SSRI exposure and persistent sexual adverse effects. Treatment options for persistent dysfunctions remain limited, but novel therapeutic approaches may be required in order to address an otherwise neglected need for sexual well-being.
PGAD, PSSD, SSRI, antidepressants, sexual dysfunction
1053-1067
Tarchi, Livio
930e92fc-d6f5-4522-a036-502bb1e80c8d
Merola, Giuseppe Pierpaolo
26718e7b-4f23-4f02-8907-8fdfb313f072
Baccaredda-Boy, Ottone
3308259e-fffc-4bc3-8281-adb0e6671bee
Arganini, Francesca
e9117f39-1274-4bed-b9da-f0b917e79a04
Cassioli, Emanuele
59c438e3-3c89-499e-a411-c3a72a0b5512
Rossi, Eleonora
b9834cb9-1bb6-4975-8b53-87f107525bb9
Maggi, Mario
cedf89b8-f442-4f4d-9918-5b29c5451814
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Ricca, Valdo
9eb01b55-e905-4887-b643-aad523e23b7d
Castellini, Giovanni
86c3e41e-29f3-49f7-bc2e-7c757a83501f
October 2023
Tarchi, Livio
930e92fc-d6f5-4522-a036-502bb1e80c8d
Merola, Giuseppe Pierpaolo
26718e7b-4f23-4f02-8907-8fdfb313f072
Baccaredda-Boy, Ottone
3308259e-fffc-4bc3-8281-adb0e6671bee
Arganini, Francesca
e9117f39-1274-4bed-b9da-f0b917e79a04
Cassioli, Emanuele
59c438e3-3c89-499e-a411-c3a72a0b5512
Rossi, Eleonora
b9834cb9-1bb6-4975-8b53-87f107525bb9
Maggi, Mario
cedf89b8-f442-4f4d-9918-5b29c5451814
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Ricca, Valdo
9eb01b55-e905-4887-b643-aad523e23b7d
Castellini, Giovanni
86c3e41e-29f3-49f7-bc2e-7c757a83501f
Tarchi, Livio, Merola, Giuseppe Pierpaolo, Baccaredda-Boy, Ottone, Arganini, Francesca, Cassioli, Emanuele, Rossi, Eleonora, Maggi, Mario, Baldwin, David S., Ricca, Valdo and Castellini, Giovanni
(2023)
Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: a systematic review.
Pharmacoepidemiology and Drug Safety, 32 (10), .
(doi:10.1002/pds.5653).
Abstract
Purpose: Adverse effects of selective serotonin reuptake inhibitors (SSRIs) on sexual function have been an important area of research for many years. However, the duration of SSRI-associated sexual adverse effects, and their possible persistence after treatment discontinuation, is still uncertain. The aims of the current systematic review were first to identify existing evidence of sexual dysfunction following SSRI discontinuation, and to provide an account of reported symptoms and proposed treatment options; and second, to establish whether current literature allows accurate estimates of the prevalence of such sexual dysfunction. Methods: A systematic review was conducted on PubMed, Embase, and Google Scholar; papers with clinical data regarding patients with persistent sexual dysfunction after SSRI treatment suspension were included. Results: Overall, two retrospective interventional studies, six observational studies and 11 case reports were judged eligible for inclusion. It was not possible to determine reliable estimates of prevalence. Similarly, a cause-effect relationship between SSRI exposure and persistent sexual impairment could not be ascertained. Nonetheless, the potential for continued sexual disturbances despite discontinuation could not be entirely ruled out. Conclusions: There is a need to investigate a possible dose–response relationship between SSRI exposure and persistent sexual adverse effects. Treatment options for persistent dysfunctions remain limited, but novel therapeutic approaches may be required in order to address an otherwise neglected need for sexual well-being.
Text
PSSD_Manuscript_revised-DSB-120423
- Accepted Manuscript
More information
Accepted/In Press date: 7 June 2023
e-pub ahead of print date: 9 June 2023
Published date: October 2023
Additional Information:
Publisher Copyright:
© 2023 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd.
Keywords:
PGAD, PSSD, SSRI, antidepressants, sexual dysfunction
Identifiers
Local EPrints ID: 477864
URI: http://eprints.soton.ac.uk/id/eprint/477864
ISSN: 1053-8569
PURE UUID: 687b6f1d-14ec-4294-b686-3e4f9edd71cd
Catalogue record
Date deposited: 15 Jun 2023 16:58
Last modified: 07 Jun 2024 04:01
Export record
Altmetrics
Contributors
Author:
Livio Tarchi
Author:
Giuseppe Pierpaolo Merola
Author:
Ottone Baccaredda-Boy
Author:
Francesca Arganini
Author:
Emanuele Cassioli
Author:
Eleonora Rossi
Author:
Mario Maggi
Author:
Valdo Ricca
Author:
Giovanni Castellini
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics